TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ZYME

Zymeworks Inc.

Healthcare · Biotechnology

26.60$ -3.3% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ZYME
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+478.4% +14.0% +370.2% +2.4% -44.3% +31.8% -31.5% +1,446.0% -81.6% +0.4% +38.9%
+133.0% +45.7% +15.7% +38.4% +105.7% +45.9% +16.8% +4.6% -31.5% -92.2% -3.6%
+399.3% -265.1% -31.5% +1,446.0% -116.2% +38.9%
+95.3% +49.3% +13.4% +35.8% +108.6% +42.5% +18.5% +4.4% -31.1% -6.3% +1.8%
+32.2% +140.6% +47.8% +58.8% +112.9% -7.7% -26.5% +72.4% -4.0% -12.6% +0.0%
+105.4% +62.4% +23.1% +45.5% -26.0% +255.2% +7.0% +16.4% -74.8% +200.3% -7.0%
-205.8%
+100.0% +5,177.8% +20.0% -85.4% +6,572.9% +59.1% -27.0% -72.0%
-188.2%
-15,026.5% +389.0% -73.2% -26.3% -220.3% -105.2% -77.4%
-195.4%
-184.7%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?